Patent · US Active

Human β-adrenergic receptor kinase polypeptide and methods

US8263378B2 · kind B2 · utility

0Cited by
18References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2010
Grant dateSep 11, 2012
Priority date—
Expiry dateOct 2, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/70
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.